The participants in the only previous study of hepcidin levels in patients with Type 2 diabetes had significantly higher serum creatinine and higher BMI than control subjects 16, suggesting that the higher hepcidin levels in patients with Type 2 diabetes were secondary to differences in renal function or BMI. The gene discussed is HAMP; the disease is type 2 diabetes mellitus.